The efficacy of energy‐based devices combination therapy for melasma
- 4 March 2021
- journal article
- review article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (3), e14927
- https://doi.org/10.1111/dth.14927
Abstract
Melasma is a recalcitrant pigmentary disease with a complex pathogenesis. Monotherapy often results in unsatisfactory results with high recurrence rate. In this review article, we evaluate efficacy of energy‐based devices combination therapy for melasma. We reviewed published literature since 2010 up to November 2020 regarding adjuvant therapy of energy‐based devices with other treatment modalities in the treatment of melasma. After final selection, we assessed 49 articles. Energy‐based devices include lasers, non‐coherent lights, radiofrequency, iontophoresis, sonophoresis, microneedling, and microdermabrasion. Adjuvant therapies other than energy‐based devices were lightening agents, chemical peels, platelet rich plasma (PRP) and mesotherapy. Combination of Q‐switched neodymium‐doped: yttrium, aluminum, and garnet (QSNY) with either intense pulsed light therapy (IPL) or pulsed‐dye laser (PDL) are recommended in recalcitrant melasma in patients with light skin photo types and with dilated skin vessels (especially with PDL). Combination of fractional microneedling radiofrequency or microneedling with QSNY leads to promising results and is a safe treatment modality, especially in darker skin types. Application of topical lightening agents in combination with laser therapy leads to higher efficacy with less adverse effects (post‐inflammatory hyperpigmentation) and rebound of melasma. Combination of ablative techniques with QSNY is not recommended, due to the high risk of permanent adverse effects such as guttate hypopigmentation and exacerbation of melasma.Keywords
This publication has 51 references indexed in Scilit:
- A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasmaJournal of Cutaneous and Aesthetic Surgery, 2013
- Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasmaDermatologic Therapy, 2012
- Intense Pulsed Light and Low-Fluence Q-Switched Nd:YAG Laser Treatment in Melasma PatientsAnnals of Dermatology, 2012
- A comparison of low-fluence 1064-nm Q-switched Nd: YAG laser with topical 20% azelaic acid cream and their combination in melasma in Indian patientsJournal of Cutaneous and Aesthetic Surgery, 2012
- Skin Needling to Enhance Depigmenting Serum Penetration in the Treatment of MelasmaPlastic Surgery International, 2011
- Sequential Treatment with Triple Combination Cream and Intense Pulsed Light is More Efficacious than Sequential Treatment with an Inactive (Control) Cream and Intense Pulsed Light in Patients with Moderate to Severe MelasmaDermatologic Surgery, 2011
- Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser for Melasma with Pre- or Post-Treatment Triple Combination CreamDermatologic Surgery, 2010
- Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminum Garnet (1,064 nm) Laser for the Treatment of Facial Melasma in AsiansDermatologic Surgery, 2010
- Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: A prospective studyJournal of Cosmetic and Laser Therapy, 2010
- Guidelines for clinical trials in melasmaBritish Journal of Dermatology, 2006